Showing results (11-20 of 172) with videos related to
Sort By:
Pageof 18
Cancer Treatment Reviews|February 2, 2016
Targeting protein kinases to reverse multidrug resistance in sarcomaHua Chen, Jacson Shen, Edwin Choy, et al.Current Treatment Options in Oncology|March 6, 2023
Trimodality Treatment of Extremity Soft Tissue Sarcoma: Where Do We Go Now?Sapna Oberoi, Edwin Choy, Yen-Lin Chen, et al.Cellular Oncology (Dordrecht, Netherlands)|March 1, 2017
Inhibition of CDK4 sensitizes multidrug resistant ovarian cancer cells to paclitaxel by increasing apoptosissYan Gao, Jacson Shen, Edwin Choy, et al.Oncotarget|March 24, 2018
Targeting DYRK1B suppresses the proliferation and migration of liposarcoma cellsHua Chen, Jacson Shen, Edwin Choy, et al.Medicine|November 22, 2018
Management of disseminated intravascular coagulation in a patient with hepatic angiosarcoma: A case reportEmily A Rosen, Mounica Vallurupalli, Edwin Choy, et al.Oncoimmunology|January 23, 2015
Targeting programmed cell death ligand 1 in osteosarcoma: an auto-commentary on therapeutic potentialJacson K Shen, Gregory M Cote, Edwin Choy, et al.Biochimica Et Biophysica Acta. Reviews on Cancer|March 1, 2017
Autophagy as a potential target for sarcoma treatmentLi Min, Edwin Choy, Raphael E Pollock, et al.Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|September 13, 2012
Targeting hedgehog-GLI-2 pathway in osteosarcomaWen Yang, Xianzhe Liu, Edwin Choy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2017
Expression and Therapeutic Potential of SOX9 in ChordomaHua Chen, Cassandra C Garbutt, Dimitrios Spentzos, et al.Journal of Biomolecular Screening|February 13, 2010
Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assayMichiro Susa, Edwin Choy, Cao Yang, et al.Pageof 18